Genome Biologics Company
Genome Biologics identifies novel tissue-specific RNAi therapies targeting the transcriptome of cardiovascular and cardiometabolic disease
Industry:
Early Drug Development
Investors Number:
1.0
Last Funding Date:
2018-09-01
Technology:
Biotechnology, Genetics, Pharmaceutical, Therapeutics
Founded Date:
2017-01-01
Headquarters:
Hessen, Sachsen-Anhalt, Germany
Total Funding:
2470000.0
Last Funding Type:
Grant
Employee Number:
11-50